Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.66 |
| ▸ | ELANE | P08246 | 5/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.66 |
| ▸ | HPGD | P15428 | 2/20 | 0.66 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.66 |
| ▸ | GLA | P06280 | 1/20 | 0.66 |
| ▸ | MEN1 | O00255 | 3/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.64 |
| ▸ | USP2 | O75604 | 1/20 | 0.64 |
| ▸ | RECQL | P46063 | 2/20 | 0.56 |
| ▸ | PIM1 | P11309 | 2/20 | 0.54 |
| ▸ | ACLY | P53396 | 4/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.46 |
| ▸ | RELA | Q04206 | 1/20 | 0.46 |
| ▸ | IDO1 | P14902 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Parietin SCHEMBL16226462 | 1.00 | MAPT (0.66) | MAPTKDM4EELANEALDH1A1HPGD | |
| SCHEMBL23522375 | 0.88 | ELANE (0.70) | MAPTKDM4EELANEALDH1A1HPGD | |
| SCHEMBL16226194 | 0.88 | ELANE (0.69) | MAPTKDM4EELANEALDH1A1HPGD | |
| SCHEMBL29360014 | 0.86 | ELANE (0.60) | MAPTKDM4EELANEALDH1A1HPGD | |
| SCHEMBL16226377 | 0.85 | ELANE (0.70) | MAPTKDM4EELANEALDH1A1HPGD | |
| SCHEMBL16227260 | 0.84 | ELANE (0.61) | MAPTKDM4EELANEALDH1A1HPGD | |
| SCHEMBL16226813 | 0.84 | ELANE (0.61) | MAPTKDM4EELANEALDH1A1HPGD | |
| Catenarin SCHEMBL29359362 | 0.84 | MEN1 (0.72) | MAPTKDM4EELANEALDH1A1HPGD | |
| Catenarin SCHEMBL9175437 | 0.84 | MEN1 (0.72) | MAPTKDM4EELANEALDH1A1HPGD | |
| SCHEMBL16226983 | 0.84 | ELANE (0.83) | MAPTKDM4EELANEALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4635293-A2 | PRODUCTION OF COLOURED FUNGAL MYCELIUM | Mushlabs GmbH (DE) | 2025-10-22 | — | — | EP | claimed |
| US-20250207082-A1 | PRODUCTION OF COLOURED FUNGAL MYCELIUM | MUSHLABS GMBH (DE) | 2025-06-26 | — | — | US | claimed |
| EP-4337758-B1 | PRODUCTION OF COLOURED FUNGAL MYCELIUM | MUSHLABS GMBH (DE) | 2025-06-04 | — | — | EP | claimed |
| US-12195726-B2 | Production of coloured fungal mycelium | MUSHLABS GMBH (DE) | 2025-01-14 | — | — | US | claimed |
| US-20240124833-A1 | PRODUCTION OF COLOURED FUNGAL MYCELIUM | MUSHLABS GMBH (DE) | 2024-04-18 | — | — | US | claimed |
| EP-4337758-A1 | PRODUCTION OF COLOURED FUNGAL MYCELIUM | Mushlabs GmbH (DE) | 2024-03-20 | — | — | EP | claimed |
| WO-2023161398-A1 | PRODUCTION OF COLOURED FUNGAL MYCELIUM | MUSHLABS GMBH (DE) | 2023-08-31 | — | — | WO | claimed |
| EP-3943085-A2 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH Zurich (CH) | 2022-01-26 | — | — | EP | claimed |
| US-20250376674-A1 | SPLIT PRIME EDITORS | PRIME MEDICINE INC (US) | 2025-12-11 | — | — | US | disclosed |
| US-20250360073-A1 | SOLUBILIZING PIGMENTS EXTRACTED FROM FUNGI FOR APPLICATIONS SUCH AS COSMETIC PRODUCTS | ADLER JESSE (US) | 2025-11-27 | — | — | US | disclosed |
| EP-4635293-A2 | PRODUCTION OF COLOURED FUNGAL MYCELIUM | Mushlabs GmbH (DE) | 2025-10-22 | — | — | EP | disclosed |
| US-20250207082-A1 | PRODUCTION OF COLOURED FUNGAL MYCELIUM | MUSHLABS GMBH (DE) | 2025-06-26 | — | — | US | disclosed |
| EP-4337758-B1 | PRODUCTION OF COLOURED FUNGAL MYCELIUM | MUSHLABS GMBH (DE) | 2025-06-04 | — | — | EP | disclosed |
| WO-2025059358-A1 | FUNGAL STRAINS HAVING REDUCED OR ELIMINATED MYCOTOXIN, ETHANOL, AND/OR PIGMENT PRODUCTION CAPACITY | THE FYNDER GROUP, INC. (US) | 2025-03-20 | — | — | WO | disclosed |
| US-20240124833-A1 | PRODUCTION OF COLOURED FUNGAL MYCELIUM | MUSHLABS GMBH (DE) | 2024-04-18 | — | — | US | disclosed |
| EP-4337758-A1 | PRODUCTION OF COLOURED FUNGAL MYCELIUM | Mushlabs GmbH (DE) | 2024-03-20 | — | — | EP | disclosed |
| WO-2023161398-A1 | PRODUCTION OF COLOURED FUNGAL MYCELIUM | MUSHLABS GMBH (DE) | 2023-08-31 | — | — | WO | disclosed |
| US-20230130204-A1 | METHOD OF DIAGNOSING A DYSBIOSIS | smartDNA Pty Ltd (AU) | 2023-04-27 | — | — | US | disclosed |
| US-11447811-B2 | Method of diagnosing a dysbiosis | smartDNA Pty Ltd (AU) | 2022-09-20 | — | — | US | disclosed |
| EP-3943085-A2 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH Zurich (CH) | 2022-01-26 | — | — | EP | disclosed |